TI
WX

Telemetry Investments’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Telemetry Investments’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,500
Closed -$454K – 140
2015
Q3 		$454K Buy
+10,500
New +$443K 0.19% 87

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Telemetry Investments's WX Position: Q4 2015 in Review

Telemetry Investments sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 10,500 shares — an estimated $454K sold.

Telemetry Investments first reported a position in WX in Q3 2015 and held it in 1 quarter. The position peaked at $454K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Telemetry Investments reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Telemetry Investments sold 10,500 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $454K.
  • Telemetry Investments first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q3 2015 and held it in 1 quarter.
  • Telemetry Investments's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $454K in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Telemetry Investments's 13F filing for Q4 2015, filed 16 Feb 2016.